Book Text

REFERENCES

151. Jones EA, Bergasa NV: The pruritus of cholestasis and the opioid system. JAMA 268:3359–3362, 1992.

152. Etches RC: Respiratory depression associated with patient-controlled analgesia: a review of eight cases. Can J Anaesth 41:125–232, 1994.

153. Forbes AR, Horrigan RW: Mucociliary flow in the trachea during anesthesia with enflurane, ether, nitrous oxide, and morphine. Anesthesiology 46:319–321, 1977.

154. Selwyn DA, Raphael JH, Lambert DG, Langton JA: Effects of morphine on human nasal cilia beat frequency in vitro. Br J Anaesth 76:274–277, 1996.

155. Jaeckle KA, Digre KB, Jones CR, et al: Central neurogenic hyperventilation: pharmacologic intervention with morphine sulfate and correlative analysis of respiratory, sleep, and ocular motor dysfunction. Neurology 40:1715–1720, 1990.

156. Tobias JD, Heideman RL: Primary central hyperventilation in a child with a brainstem glioma: Management with continuous intravenous fentanyl. Pediatrics 88:818–820, 1991.

157. Bohrer H, Fleischer F, Werning P: Tussive effect of a fentanyl bolus administered through a central venous catheter. Anaesthesia 45:18–21, 1990.

158. Ruiz Neto PP, Auler Junior JO: Respiratory mechanical properties during fentanyl and alfentanil anaesthesia. Can J Anaesth 39:458–465, 1992.

159. Tabatabai M, Kitahata LM, Collins JG: Disruption of the rhythmic activity of the medullary inspiratory neurons and phrenic nerve by fentanyl and reversal with nalbuphine. Anesthesiology 70:489–495, 1989.

160. Sarton E, Teppema L, Dahan A: Sex differences in morphine-induced ventilatory depression reside within the peripheral chemoreflex loop. Anesthesiology 90:1329–1338, 1999.

161. Smart JA, Pallett EJ, Duthie DJ: Breath interval as a measure of dynamic opioid effect. Br J Anaesth 84:735–738, 2000.

162. Bailey PL, Streisand JB, East KA, et al: Differences in magnitude and duration of opioid-induced respiratory depression and analgesia with fentanyl and sufentanil. Anesth Analg 70:8–15, 1990.

163. Ausems ME, Hug CC Jr, Stanski DR, Burm AG: Plasma concentrations of alfentanil required to supplement nitrous oxide anesthesia for general surgery. Anesthesiology 65:362–367, 1986.

164. Glass PS, Iselin-Chaves IA, Goodman D, et al: Determination of the potency of remifentanil compared with alfentanil using ventilatory depression as the measure of opioid effect. Anesthesiology 90:1556–1563, 1999.

165. Combes X, Cerf C, Bouleau D: The effects of residual pain on oxygenation and breathing pattern during morphine analgesia. Anesth Analg 90:156–160, 2000.

166. Knape JT: Early respiratory depression resistant to naloxone following epidural buprenorphine. Anesthesiology 64:382–384, 1986.

167. Krenn H, Jellinek H, Haumer H, et al: Naloxone-resistant respiratory depression and neurological eye symptoms after intrathecal morphine. Anesth Analg 91:432–433, 2000.

168. Arunasalam K, Davenport HT, Painter S, Jones JG: Ventilatory response to morphine in young and old subjects. Anaesthesia 38:529–533, 1983.

169. Furst SR, Weinger MB: Dexmedetomidine, a selective alpha 2-agonist, does not potentiate the cardiorespiratory depression of alfentanil in the rat. Anesthesiology 72:882–888, 1990.

170. Rawal N, Wattwil M: Respiratory depression after epidural morphine—an experimental and clinical study. Anesth Analg 63:8–14, 1984.

171. Nishino T, Hiraga K, Fujisato M, et al: Breathing patterns during postoperative analgesia in patients after lower abdominal operations. Anesthesiology 69:967–972, 1988.

172. Pelligrino DA, Riegler FX, Albrecht RF: Ventilatory effects of fourth cerebroventricular infusions of morphine-6- or morphine-3-glucuronide in the awake dog. Anesthesiology 71:936–940, 1989.

173. Peat SJ, Hanna MH, Woodham M, et al: Morphine-6-glucuronide: effects on ventilation in normal volunteers. Pain 45:101–104, 1991.

174. Koehntop DE, Rodman JH, Brundage DM, et al: Pharmacokinetics of fentanyl in neonates. Anesth Analg 65:227–232, 1986.

175. Robbins GR, Wynands JE, Whalley DG, et al: Pharmacokinetics of alfentanil and clinical responses during cardiac surgery. Can J Anaesth 37:52–57, 1990.

176. Hug CC Jr, Hall RI, Angert KC, et al: Alfentanil plasma concentration vs. effect relationships in cardiac surgical patients. Br J Anaesth 61:435–440, 1988.

177. Feldman PD, Parveen N, Sezen S: Cardiovascular effects of Leu-enkephalin in the nucleus tractus solitarius of the rat. Brain Res 709:331–333, 1996.

178. Keay KA, Crowfoot LJ, Floyd NS, et al: Cardiovascular effects of microinjections of opioid agonists into the 'Depressor Region' of the ventrolateral periaqueductal gray region. Brain Res 762:61–71, 1997.

179. Thomson IR, Putnins CL, Friesen RM: Hyperdynamic cardiovascular responses to anesthetic induction with high-dose fentanyl. Anesth Analg 65:91–95, 1986.

180. Zhang CC, Su JY, Calkins D: Effects of alfentanil on isolated cardiac tissues of the rabbit. Anesth Analg 71:268–274, 1990.

181. Helgesen KG, Ellingsen O, Ilebekk A: Inotropic effect of meperidine: influence of receptor and ion channel blockers in the rat atrium. Anesth Analg 70:499–506, 1990.

182. Nakae Y, Fujita S, Namiki A: Morphine enhances myofilament CA(2⁺ ) sensitivity in intact guinea pig beating hearts. Anesth Analg 92:602–608, 2001.

183. Llobel F, Laorden ML: Effects of morphine on atrial preparations obtained from nonfailing and failing human hearts. Br J Anaesth 76:106–110, 1996.

184. Mathews HM, Furness G, Carson IW, et al: Comparison of sufentanil-oxygen and fentanyl-oxygen anaesthesia for coronary artery bypass grafting. Br J Anaesth 60:530–535, 1988.

185. James MK, Vuong A, Grizzle MK, et al: Hemodynamic effects of GI 87084B, an ultra-short acting mu-opioid analgesic, in anesthetized dogs. J Pharmacol Exp Ther 263:84–91, 1992.

186. Royster RL, Keeler DK, Haisty WK, et al: Cardiac electrophysiologic effects of fentanyl and combinations of fentanyl and neuromuscular relaxants in pentobarbital-anesthetized dogs. Anesth Analg 67:15–20, 1988.

187. Blair JR, Pruett JK, Introna RP, et al: Cardiac electrophysiologic effects of fentanyl and sufentanil in canine cardiac Purkinje fibers. Anesthesiology 71:565–570, 1989.

188. Weber G, Stark G, Stark U: Direct cardiac electrophysiologic effects of sufentanil and vecuronium in isolated guinea-pig hearts. Acta Anaesthesiol Scand 39:1071–1074, 1995.

189. Blair JR, Pruett JK, Crumrine RS, Balser JJ: Prolongation of QT interval in association with the administration of large doses of opiates. Anesthesiology 67:442–443, 1997.

190. Sharpe MD, Dobkowski WB, Murkin JM, et al: Alfentanilmidazolam anaesthesia has no electrophysiological effects upon the normal conduction system or accessory pathways in patients with Wolff-Parkinson-White syndrome. Can J Anaesth 39:816–821, 1992.

191. Sharpe MD, Dobkowski WB, Murkin JM, et al: The electrophysiologic effects of volatile anesthetics and sufentanil on the normal atrioventricular conduction system and accessory pathways in Wolff-Parkinson-White syndrome. Anesthesiology 80:63–70, 1994.

192. Schmeling WT, Kampine JP, Warltier DC: Negative chronotropic actions of sufentanil and vecuronium in chronically instrumented dogs pretreated with propranolol and/or diltiazem. Anesth Analg 69:4–14, 1989.

429

193. Atlee JL, 3rd, Bosnjak ZJ: Mechanisms for cardiac dysrhythmias during anesthesia. Anesthesiology 72:347–374, 1990.

194. Saini V, Carr DB, Hagestad EL, et al: Antifibrillatory action of the narcotic agonist fentanyl. Am Heart J 115:598–605, 1988.

195. McIntosh M, Kane K, Parratt J: Effects of selective opioid receptor agonists and antagonists during myocardial ischaemia. Eur J Pharmacol 210:37–44, 1992.

196. Chinzei M, Morita S, Chinzei T, et al: Effects of isoflurane and fentanyl on ischemic myocardium in dogs: Assessment by end-systolic measurements. J Cardiothorac Vasc Anesth 5:243–249, 1991.

197. Kim YD, Danchek M, Myers AK, et al: Anaesthetic modification of regional myocardial functional adjustments during myocardial ischaemia: Halothane vs fentanyl. Br J Anaesth 68:286–292, 1992.

198. White JL, Myers AK, Analouei A, Kim YD: Functional recovery of stunned myocardium is greater with halothane than fentanyl anaesthesia in dogs. Br J Anaesth 73:214–219, 1994.

199. Schultz JE, Hsu AK, Gross GJ: Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res 78:1100–1104, 1996.

200. McPherson BC, Yao Z: Signal transduction of opioid-induced cardioprotection in ischemia-reperfusion. Anesthesiology 94:1082–1088, 2001.

201. Kato R, Foex P: Fentanyl reduces infarction but not stunning via delta-opioid receptors and protein kinase C in rats. Br J Anaesth 84:608–614, 2000.

202. Kato R, Ross S, Foex P: Fentanyl protects the heart against ischaemic injury via opioid receptors, adenosine A1 receptors and KATP channel linked mechanisms in rats. Br J Anaesth 84:204–214, 2000.

203. Warltier DC, Pagel PS, Kersten JR: Approaches to the prevention of perioperative myocardial ischemia. Anesthesiology 92:253–259, 2000.

204. Helman JD, Leung JM, Bellows WH, et al: The risk of myocardial ischemia in patients receiving desflurane versus sufentanil anesthesia for coronary artery bypass graft surgery. The S.P.I. Research Group. Anesthesiology 77:47–62, 1992.

205. Leung JM, Goehner P, O'Kelly BF, et al: Isoflurane anesthesia and myocardial ischemia: Comparative risk versus sufentanil anesthesia in patients undergoing coronary artery bypass graft surgery. The SPI (Study of Perioperative Ischemia) Research Group. Anesthesiology 74:838–847, 1991.

206. Miller DR, Wellwood M, Teasdale SJ, et al: Effects of anesthetic induction on myocardial function and metabolism: A comparison of fentanyl, sufentanil and alfentanil. Can J Anaesth 35:219–233, 1988.

207. Slogoff S, Keats AS: Randomized trial of primary anesthetic agents on outcome of coronary artery bypass operations. Anesthesiology 70:179–188, 1989.

208. Blaise GA, Witzeling TM, Sill JC, et al: Fentanyl is devoid of major effects on coronary vasoreactivity and myocardial metabolism in experimental animals. Anesthesiology 72:535–541, 1990.

209. Yamanoue T, Brum JM, Estafanous FG, et al: Effects of opioids on vasoresponsiveness of porcine coronary artery. Anesth Analg 74:889–896, 1992.

210. Nauta J, Stanley TH, de Lange S, et al: Anaesthetic induction with alfentanil: Comparison with thiopental, midazolam, and etomidate. Can Anaesth Soc J 30:53–60, 1983.

211. Ebert TJ, Kotrly KJ, Madsen KE, et al: Fentanyl-diazepam anesthesia with or without N₂ O does not attenuate cardiopulmonary baroreflex-mediated vasoconstrictor responses to controlled hypovolemia in humans. Anesth Analg 67:548–554, 1988.

212. Murat I, Levron JC, Berg A, Saint Maurice C: Effects of fentanyl on baroreceptor reflex control of heart rate in newborn infants. Anesthesiology 68:717–722, 1988.

213. Flacke JW, Flacke WE, Bloor BC, et al: Histamine release by four narcotics: A double-blind study in humans. Anesth Analg 66:723–730, 1987.

214. Moss J, Rosow CE: Histamine release by narcotics and muscle relaxants in humans. Anesthesiology 59:330–339, 1983.

215. Gaumann DM, Yaksh TL, Tyce GM, Lucas DL: Opioids preserve the adrenal medullary response evoked by severe hemorrhage: Studies on adrenal catecholamine and met-enkephalin secretion in halothane anesthetized cats. Anesthesiology 68:743–753, 1988.

216. White DA, Reitan JA, Kien ND, Thorup SJ: Decrease in vascular resistance in the isolated canine hind limb after graded doses of alfentanil, fentanyl, and sufentanil. Anesth Analg 71:29–34, 1990.

217. Chrousos GP, Gold PW: The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA 267:1244–1252, 1992.

218. Anand KJ, Hansen DD, Hickey PR: Hormonal-metabolic stress responses in neonates undergoing cardiac surgery. Anesthesiology 73:661–670, 1990.

219. Delitala G, Trainer PJ, Oliva O, et al: Opioid peptide and alpha-adrenoceptor pathways in the regulation of the pituitary-adrenal axis in man. J Endocrinol 141:163–168, 1994.

220. Giesecke K, Hamberger B, Jarnberg PO, et al: High- and low-dose fentanyl anaesthesia: Hormonal and metabolic responses during cholecystectomy. Br J Anaesth 61:575–582, 1988.

221. Ellis DJ, Steward DJ: Fentanyl dosage is associated with reduced blood glucose in pediatric patients after hypothermic cardiopulmonary bypass. Anesthesiology 72:812–815, 1990.

222. Boulton AJ, Wilson N, Turnbull KW, Yip RW: Haemodynamic and plasma vasopressin responses during high-dose fentanyl or sufentanil anaesthesia. Can Anaesth Soc J 33:475–483, 1986.

223. Moller IW, Krantz T, Wandall E, Kehlet H: Effect of alfentanil anaesthesia on the adrenocortical and hyperglycaemic response to abdominal surgery. Br J Anaesth 57:591–594, 1985.

224. Yeager MP, Glass DD, Neff RK, Brinck Johnsen T: Epidural anesthesia and analgesia in high-risk surgical patients. Anesthesiology 66:729–736, 1987.

225. Anand KJ, Hickey PR: Halothane-morphine compared with high-dose sufentanil for anesthesia and postoperative analgesia in neonatal cardiac surgery. N Engl J Med 326:1–9, 1992.

226. Mangano DT, Siliciano D, Hollenberg M, et al: Postoperative myocardial ischemia. Therapeutic trials using intensive analgesia following surgery. The Study of Perioperative Ischemia (SPI) Research Group. Anesthesiology 76:342–353, 1992.

227. Tuman KJ, McCarthy RJ, Spiess BD, et al: Does choice of anesthetic agent significantly affect outcome after coronary artery surgery? Anesthesiology 70:189–198, 1989.

228. Plunkett JJ, Reeves JD, Ngo L, et al: Urine and plasma catecholamine and cortisol concentrations after myocardial revascularization. Modulation by continuous sedation. Multicenter Study of Perioperative Ischemia (McSPI) Research Group, and the Ischemia Research and Education Foundation (IREF). Anesthesiology 86:785–796, 1997.

229. Nestler EJ, Aghajanian GK: Molecular and cellular basis of addiction. Science 278:58–63, 1997.

230. Chan KW, Duttory A, Yoburn BC: Magnitude of tolerance to fentanyl is independent of mu-opioid receptor density. Eur J Pharmacol 319:225–228, 1997.

231. Maze M: Why does insensitivity to opioid narcotics develop? Anesthesiology 87:1033–1034, 1997.

232. Kissin I, Lee SS, Arthur GR, Bradley EL Jr: Time course characteristics of acute tolerance development to continuously infused alfentanil in rats. Anesth Analg 83:600–605, 1996.

233. Kissin I, Brown PT, Robinson CA, Bradley EL Jr: Acute tolerance in morphine analgesia: continuous infusion and single injection in rats. Anesthesiology 74:166–171, 1991.

234. Chia YY, Liu K, Wang JJ, et al: Intraoperative high dose fentanyl induces postoperative fentanyl tolerance. Can J Anaesth 46:872–877, 1999.

235. Vinik HR, Kissin I: Rapid development of tolerance to analgesia during remifentanil infusion in humans. Anesth Analg 86:1307–1311, 1998.

430

236. Guignard B, Bossard AE, Coste C, et al: Acute opioid tolerance: Intraoperative remifentanil increases postoperative pain and morphine requirement. Anesthesiology 93:409–417, 2000.

237. Schraag S, Checketts MR, Kenny GN: Lack of rapid development of opioid tolerance during alfentanil and remifentanil infusions for postoperative pain. Anesth Analg 89:753–757, 1999.

238. Gustorff B, Nahlik G, Hoerauf KH, Kress HG: The absence of acute tolerance during remifentanil infusion in volunteers. Anesth Analg 94:1223–1228, 2002.

239. Celerier E, Rivat C, Jun Y, et al: Long-lasting hyperalgesia induced by fentanyl in rats: Preventive effect of ketamine. Anesthesiology 92:465–472, 2000.

240. Mao J, Price DD, Mayer DJ: Mechanisms of hyperalgesia and morphine tolerance: A current view of their possible interactions. Pain 62:259–274, 1995.

241. Li X, Angst MS, Clark JD: Opioid-induced hyperalgesia and incisional pain. Anesth Analg 93:204–209, 2001.

242. Li X, Clark JD: Hyperalgesia during opioid abstinence: Mediation by glutamate and substance p. Anesth Analg 95:979–984, 2002.

243. Kissin I, Bright CA, Bradley EL Jr: Acute tolerance to continuously infused alfentanil: The role of cholecystokinin and N-methyl-D-aspartate-nitric oxide systems. Anesth Analg 91:110–116, 2000.

244. Li JY, Wong CH, Huang EY, et al: Modulations of spinal serotonin activity affect the development of morphine tolerance. Anesth Analg 92:1563–1568, 2001.

245. Laulin JP, Maurette P, Corcuff JB, et al: The role of ketamine in preventing fentanyl-induced hyperalgesia and subsequent acute morphine tolerance. Anesth Analg 94:1263–1269, 2002.

246. Kissin I, Bright CA, Bradley EL Jr: The effect of ketamine on opioid-induced acute tolerance: Can it explain reduction of opioid consumption with ketamine-opioid analgesic combinations? Anesth Analg 91:1483–1488, 2000.

247. Stein C, Pfluger M, Yassouridis A, et al: No tolerance to peripheral morphine analgesia in presence of opioid expression in inflamed synovia. J Clin Invest 98:793–799, 1996.

248. Duttaroy A, Yoburn BC: The effect of intrinsic efficacy on opioid tolerance. Anesthesiology 82:1226–1236, 1995.

249. Ouellet DM, Pollack GM: Pharmacodynamics and tolerance development during multiple intravenous bolus morphine administration in rats. J Pharmacol Exp Ther 281:713–720, 1997.

250. Hanks GW, Forbes K: Opioid responsiveness. Acta Anaesthesiol Scand 41:154–158, 1997.

251. Kienbaum P, Thurauf N, Michel MC, et al: Profound increase in epinephrine concentration in plasma and cardiovascular stimulation after mu-opioid receptor blockade in opioid-addicted patients during barbiturate-induced anesthesia for acute detoxification. Anesthesiology 88:1154–1161, 1998.

252. Hensel M, Wolter S, Kox WJ: EEG controlled rapid opioid withdrawal under general anaesthesia. Br J Anaesth 84:236–238, 2000.

253. Kienbaum P, Heuter T, Michel MC, et al: Sympathetic neural activation evoked by mu-receptor blockade in patients addicted to opioids is abolished by intravenous clonidine. Anesthesiology 96:346–351, 2002.

254. Salas SP, Roblero JS, Lopez LF, et al: [N-methyl-Tyr1, N-methyl-Arg7-D-Leu8]-dynorphin-A-(1-8)ethylamide, a stable dynorphin analog, produces diuresis by kappa-opiate receptor activation in the rat. J Pharmacol Exp Ther 262:979–986, 1992.

255. Pesonen A, Leppaluoto J, Ruskoaho H: Mechanism of opioid-induced atrial natriuretic peptide release in conscious rats. J Pharmacol Exp Ther 254:690–695, 1990.

256. Kien ND, Reitan JA, White DA, et al: Hemodynamic responses to alfentanil in halothane-anesthetized dogs. Anesth Analg 65:765–770, 1986.

257. Drenger B, Magora F: Urodynamic studies after intrathecal fentanyl and buprenorphine in the dog. Anesth Analg 69:348–353, 1989.

258. Malinovsky JM, Le Normand L, Lepage JY, et al: The urodynamic effects of intravenous opioids and ketoprofen in humans. Anesth Analg 87:456–461, 1998.

259. Murphy DB, Sutton JA, Prescott LF, Murphy MB: Opioid-induced delay in gastric emptying: a peripheral mechanism in humans. Anesthesiology 87:765–770, 1997.

260. Kojima Y, Takahashi T, Fujina M, Owyang C: Inhibition of cholinergic transmission by opiates in ileal myenteric plexus is mediated by kappa receptor. Involvement of regulatory inhibitory G protein and calcium N-channels. J Pharmacol Exp Ther 268:965–970, 1994.

261. Dowlatshahi K, Evander A, Walther B, Skinner DB: Influence of morphine on the distal oesophagus and the lower oesophageal sphincter—a manometric study. Gut 26:802–806, 1985.

262. Schurizek BA, Willacy LH, Kraglund K, et al: Antroduodenal motility, pH and gastric emptying during balanced anaesthesia: Comparison of pethidine and fentanyl. Br J Anaesth 62:674–682, 1989.

263. Crighton IM, Martin PH, Hobbs GJ, et al: A comparison of the effects of intravenous tramadol, codeine, and morphine on gastric emptying in human volunteers. Anesth Analg 87:445–449, 1998.

264. Yukioka H, Tanaka M, Fujimori M: Recovery of bowel motility after high dose fentanyl or morphine anaesthesia for cardiac surgery. Anaesthesia 45:353–356, 1990.

265. Thorn SE, Wickbom G, Philipson L, et al: Myoelectric activity in the stomach and duodenum after epidural administration of morphine or bupivacaine. Acta Anaesthesiol Scand 40:773–778, 1996.

266. McNeill MJ, Ho ET, Kenny GN: Effect of i.v. metoclopramide on gastric emptying after opioid premedication. Br J Anaesth 64:450–452, 1990.

267. Vatashsky E, Haskel Y, Nissan S, Hanani M: Effect of morphine on the mechanical activity of common bile duct isolated from the guinea pig. Anesth Analg 66:245–248, 1987.

268. Goldberg M, Vatashsky E, Haskel Y, et al: The effect of meperidine on the guinea pig extrahepatic biliary tract. Anesth Analg 66:1282–1286, 1987.

269. Fisher DM: The "big little problem" of postoperative nausea and vomiting: Do we know the answer yet? Anesthesiology 87:1271–1273, 1997.

270. Tramer MR, Reynolds DJ, Moore RA, McQuay HJ: Efficacy, dose-response, and safety of ondansetron in prevention of postoperative nausea and vomiting: A quantitative systematic review of randomized placebo-controlled trials. Anesthesiology 87:1277–1289, 1997.

271. Watcha MF, White PF: Postoperative nausea and vomiting. Its etiology, treatment, and prevention. Anesthesiology 77:162–184, 1992.

272. Langevin S, Lessard MR, Trepanier CA, Baribault JP: Alfentanil causes less postoperative nausea and vomiting than equipotent doses of fentanyl or sufentanil in outpatients. Anesthesiology 91:1666–1673, 1999.

273. Raftery S, Sherry E: Total intravenous anaesthesia with propofol and alfentanil protects against postoperative nausea and vomiting. Can J Anaesth 39:37–40, 1992.

274. Rung GW, Claybon L, Hord A, et al: Intravenous ondansetron for postsurgical opioid-induced nausea and vomiting. S3A-255 Study Group. Anesth Analg 84:832–838, 1997.

275. Simoneau, II, Hamza MS, Mata HP, et al: The cannabinoid agonist WIN55,212-2 suppresses opioid-induced emesis in ferrets. Anesthesiology 94:882–887, 2001.

276. Bruce DL, Hinkley R, Norman PF: Fentanyl does not inhibit fertilization or early development of sea urchin eggs. Anesth Analg 64:498–500, 1985.

277. Fujinaga M, Mazze RI, Jackson EC, Baden JM: Reproductive and teratogenic effects of sufentanil and alfentanil in Sprague-Dawley rats. Anesth Analg 67:166–169, 1988.

278. Sandner-Kiesling A, Eisenach JC: Pharmacology of opioid inhibition to noxious uterine cervical distension. Anesthesiology 97:966–971, 2002.

279. Sandner-Kiesling A, Eisenach JC: Estrogen reduces efficacy of mu- but not kappa-opioid agonist inhibition in response to uterine cervical distension. Anesthesiology 96:375–379, 2002.

431

280. Gin T, Ngan Kee WD, Siu YK, et al: Alfentanil given immediately before the induction of anesthesia for elective cesarean delivery. Anesth Analg 90:1167–1172, 2000.

281. Sivalingam T, Pleuvry BJ: Actions of morphine, pethidine and pentazocine on the oestrus and pregnant rat uterus in vitro. Br J Anaesth 57:430–433, 1985.

282. Rayburn W, Rathke A, Leuschen MP, et al: Fentanyl citrate analgesia during labor. Am J Obstet Gynecol 161:202–206, 1989.

283. Wittels B, Scott DT, Sinatra RS: Exogenous opioids in human breast milk and acute neonatal neurobehavior: A preliminary study. Anesthesiology 73:864–869, 1990.

284. Spigset O: Anaesthetic agents and excretion in breast milk. Acta Anaesthesiol Scand 38:94–103, 1994.

285. Doberczak TM, Kandall SR, Wilets I: Neonatal opiate abstinence syndrome in term and preterm infants. J Pediatr 118:933–937, 1991.

286. Levy JH, Brister NW, Shearin A, et al: Wheal and flare responses to opioids in humans. Anesthesiology 70:756–760, 1989.

287. Alexander R, Hill R, Lipham WJ, et al: Remifentanil prevents an increase in intraocular pressure after succinylcholine and tracheal intubation. Br J Anaesth 81:606–607, 1998.

288. Ng HP, Chen FG, Yeong SM, et al: Effect of remifentanil compared with fentanyl on intraocular pressure after succinylcholine and tracheal intubation. Br J Anaesth 85:785–787, 2000.

289. Stefano GB, Scharrer B, Smith EM, et al: Opioid and opiate immunoregulatory processes. Crit Rev Immunol 16:109–144, 1996.

290. Nelson CJ, Dykstra LA, Lysle DT: Comparison of the time course of morphine's analgesic and immunologic effects. Anesth Analg 85:620–626, 1997.

291. Sacerdote P, Bianchi M, Gaspani L, et al: The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients. Anesth Analg 90:1411–1414, 2000.

292. Yeager MP, Procopio MA, DeLeo JA, et al: Intravenous fentanyl increases natural killer cell cytotoxicity and circulating CD16⁺ lymphocytes in humans. Anesth Analg 94:94–99, 2002.

293. Welters ID, Menzebach A, Goumon Y, et al: Morphine inhibits NF-kappa B nuclear binding in human neutrophils and monocytes by a nitric oxide-dependent mechanism. Anesthesiology 92:1677–1684, 2000.

294. Gourlay GK, Kowalski SR, Plummer JL, et al: Fentanyl blood concentration-analgesic response relationship in the treatment of postoperative pain. Anesth Analg 67:329–337, 1988.

295. Egan TD: Pharmacokinetics and rational intravenous drug selection and administration in anesthesia. Adv Anesth 12:363, 1995.

296. Roerig DL, Kotrly KJ, Vucins EJ, et al: First pass uptake of fentanyl, meperidine, and morphine in the human lung. Anesthesiology 67:466–472, 1987.

297. Boer F, Bovill JG, Burm AG, Mooren RA: Uptake of sufentanil, alfentanil and morphine in the lungs of patients about to undergo coronary artery surgery. Br J Anaesth 68:370–375, 1992.

298. Mazoit JX, Sandouk P, Scherrmann JM, Roche A: Extrahepatic metabolism of morphine occurs in humans. Clin Pharmacol Ther 48:613–618, 1990.

299. Merrell WJ, Gordon L, Wood AJ, et al: The effect of halothane on morphine disposition: relative contributions of the liver and kidney to morphine glucuronidation in the dog. Anesthesiology 72:308–314, 1990.

300. Portenoy RK, Thaler HT, Inturrisi CE, et al: The metabolite morphine-6-glucuronide contributes to the analgesia produced by morphine infusion in patients with pain and normal renal function. Clin Pharmacol Ther 51:422–431, 1992.